Plant cell technology company and producer of sustainable bioactives for consumer products, Ayana Bio, has launched its Plant Cell Advantage (PCA) ingredient portfolio.
The latest additions to the portfolio include Dog Rose PCA, Hedge Nettle PCA, and Sage PCA, expanding Ayana Bio’s offering of plant cell-cultivated health and wellness ingredients.
The new PCA ingredients are non-GMO plant powders with standardised bioactive compositions and can directly replace dog rose, hedge nettle and sage in dietary supplements and food products.
Dog Rose PCA delivers joint health and immune support, Hedge Nettle PCA provides healthy inflammatory response and antioxidants and Sage PCA offers healthy inflammatory response and cognitive support. The PCA ingredient portfolio also includes Echinacea-p PCA for immune benefits and Lemon Balm PCA for sleep and mood support, which launched in April 2023.
Ayana Bio’s PCA ingredients are developed using plant cell cultivation. Ayana Bio grows real plant cells in stainless steel tanks, delivering the health benefits of plant bioactives without the quality issues that come from the constraints of conventional agriculture, including climate change.
Ayana Bio says that its plant cell cultivation technology produces the full spectrum of bioactives found in nature – or with an even higher potency of beneficial bioactives. PCA ingredients are DNA-fingerprint certified and 100% clean label, with standardised phytocomplex, increased bioavailability, full traceability and a neutral taste and colour.
Frank Jaksch, CEO of Ayana Bio, said: “The health and wellness benefits of medicinal plants rarely come from a single bioactive. Our Plant Cell Advantage portfolio maintains the full spectrum of bioactive compounds found in nature that work together in harmony to deliver the most powerful health benefits possible. With our newest Dog Rose PCA, Hedge Nettle PCA and Sage PCA, companies can incorporate high-quality, sustainable ingredients that improve people’s quality of life.”
